Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness

K. Vaškovičová, E. Szabadosová, V. Čermák, A. Gandalovičová, L. Kasalová, D. Rösel, J. Brábek,

. 2015 ; 15 (-) : 326. [pub] 20150429

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: The local invasion of tumor cells into the surrounding tissue is the first and most critical step of the metastatic cascade. Cells can invade either collectively, or individually. Individual cancer cell invasion can occur in the mesenchymal or amoeboid mode, which are mutually interchangeable. This plasticity of individual cancer cell invasiveness may represent an escape mechanism for invading cancer cells from anti-metastatic treatment. METHODS: To identify new signaling proteins involved in the plasticity of cancer cell invasiveness, we performed proteomic analysis of the amoeboid to mesenchymal transition with A375m2 melanoma cells in a 3D Matrigel matrix. RESULTS: In this screen we identified PKCα as an important protein for the maintenance of amoeboid morphology. We found that the activation of PKCα resulted in the mesenchymal-amoeboid transition of mesenchymal K2 and MDA-MB-231 cell lines. Consistently, PKCα inhibition led to the amoeboid-mesenchymal transition of amoeboid A375m2 cells. Next, we showed that PKCα inhibition resulted in a considerable decrease in the invading abilities of all analyzed cancer cell lines. CONCLUSIONS: Our results suggest that PKCα is an important protein for maintenance of the amoeboid morphology of cancer cells, and that downregulation of PKCα results in the amoeboid to mesenchymal transition. Our data also suggest that PKCα is important for both mesenchymal and amoeboid invasiveness, making it an attractive target for anti-metastatic therapies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010251
003      
CZ-PrNML
005      
20160412122825.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12885-015-1347-1 $2 doi
024    7_
$a 10.1186/s12885-015-1347-1 $2 doi
035    __
$a (PubMed)25924946
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Vaškovičová, Katarína $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. katarina.vaskovicova@gmail.com. Current affiliation: Microscopy Unit, Institute of Experimental Medicine, The Czech Academy of Sciences, Prague, Czech Republic. katarina.vaskovicova@gmail.com.
245    10
$a PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness / $c K. Vaškovičová, E. Szabadosová, V. Čermák, A. Gandalovičová, L. Kasalová, D. Rösel, J. Brábek,
520    9_
$a BACKGROUND: The local invasion of tumor cells into the surrounding tissue is the first and most critical step of the metastatic cascade. Cells can invade either collectively, or individually. Individual cancer cell invasion can occur in the mesenchymal or amoeboid mode, which are mutually interchangeable. This plasticity of individual cancer cell invasiveness may represent an escape mechanism for invading cancer cells from anti-metastatic treatment. METHODS: To identify new signaling proteins involved in the plasticity of cancer cell invasiveness, we performed proteomic analysis of the amoeboid to mesenchymal transition with A375m2 melanoma cells in a 3D Matrigel matrix. RESULTS: In this screen we identified PKCα as an important protein for the maintenance of amoeboid morphology. We found that the activation of PKCα resulted in the mesenchymal-amoeboid transition of mesenchymal K2 and MDA-MB-231 cell lines. Consistently, PKCα inhibition led to the amoeboid-mesenchymal transition of amoeboid A375m2 cells. Next, we showed that PKCα inhibition resulted in a considerable decrease in the invading abilities of all analyzed cancer cell lines. CONCLUSIONS: Our results suggest that PKCα is an important protein for maintenance of the amoeboid morphology of cancer cells, and that downregulation of PKCα results in the amoeboid to mesenchymal transition. Our data also suggest that PKCα is important for both mesenchymal and amoeboid invasiveness, making it an attractive target for anti-metastatic therapies.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a pohyb buněk $x genetika $7 D002465
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a melanom $x genetika $x patologie $7 D008545
650    _2
$a mezoderm $x metabolismus $x patologie $7 D008648
650    _2
$a invazivní růst nádoru $x genetika $x patologie $7 D009361
650    _2
$a proteinkinasa C-alfa $x biosyntéza $x genetika $7 D051571
650    _2
$a proteomika $7 D040901
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Szabadosová, Emilia $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. emiluska@gmail.com.
700    1_
$a Čermák, Vladimír $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. cermak@natur.cuni.cz.
700    1_
$a Gandalovičová, Aneta $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. gandaloa@natur.cuni.cz.
700    1_
$a Kasalová, Lenka $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. kasalova@biotech.cz.
700    1_
$a Rösel, Daniel $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. rosel@natur.cuni.cz.
700    1_
$a Brábek, Jan $u Department of Cell Biology, Laboratory of Cancer Cell Invasion, Charles University in Prague, Prague, Czech Republic. brabek@natur.cuni.cz.
773    0_
$w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 15, č. - (2015), s. 326
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25924946 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160412122909 $b ABA008
999    __
$a ok $b bmc $g 1113680 $s 934619
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 15 $c - $d 326 $e 20150429 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...